Cardiology
New findings from Switzerland, France and the United States in the area of cardiology detailed
Published in Medical Devices and Surgical Technology Week, August 13th, 2006
Study 1: Early treatment with statins in patients after the onset of acute coronary syndromes (ACS) does not significantly reduce risk of death, myocardial infarction (MI), or stroke.
According to recent research from Switzerland, "The short-term effects of early treatment with statins in patients after the onset of ACS for the outcomes of death, MI, and stroke are unclear. The objective of this study was to evaluate relevant outcomes of patients from randomized controlled trials comparing early statin therapy with placebo or usual care at 1 and 4 months...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Cardiology
Tricuspid valve replacement bileaflet mechanical valves should be implanted vertically - Primary Aldosteronism
Primary aldosteronism is associated with partially reversible renal dysfunction - Stroke
Recurrent stroke can be prevented with lower target blood pressures - Urology
Penile prosthesis surgery patient satisfaction factors are determined - Adrenocortical Cancer
Adrenocortical carcinoma management depends on better understanding of molecular pathogenesis - Aesthetic Medicine
Lumenis launches ActiveFX procedure for skin rejuvenation - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
